Related Experiment Video
Updated: Apr 26, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Up-regulation of the interferon-related genes in BRCA2 knockout epithelial cells
Hong Xu1, Jian Xian, Emmanuelle Vire
1Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Abstract:
BRCA2 mutations are significantly associated with early-onset breast cancer, and the tumour-suppressing function of BRCA2 has been attributed to its involvement in homologous recombination (HR)-mediated DNA repair. In order to identify additional functions of BRCA2, we generated BRCA2-knockout HCT116 human colorectal carcinoma cells. Using genome-wide microarray analyses, we have discovered a link between the loss of BRCA2 and the up-regulation of a subset of interferon (IFN)-related genes, including APOBEC3F and APOBEC3G. The over-expression of IFN-related genes was confirmed in different human BRCA2(-/-) and mouse Brca2(-/-) tumour cell lines, and was independent of senescence and apoptosis. In isogenic wild-type BRCA2 cells, we observed over-expression of IFN-related genes after treatment with DNA-damaging agents, and following ionizing radiation. Cells with endogenous DNA damage because of defective BRCA1 or RAD51 also exhibited over-expression of IFN-related genes. Transcriptional activity of the IFN-stimulated response element (ISRE) was increased in BRCA2 knockout cells, and the expression of BRCA2 greatly decreased IFNα-stimulated ISRE reporter activity, suggesting that BRCA2 directly represses the expression of IFN-related genes through the ISRE. Finally, the colony-forming capacity of BRCA2 knockout cells was significantly reduced in the presence of either IFNβ or IFNγ, suggesting that IFNs may have potential as therapeutic agents in cancer cells with BRCA2 mutations. The GEO Accession No. for microarray analysis is GSE54830.
Insights
Loss of BRCA2 function in cancer cells leads to increased interferon-related gene expression. Interferons may offer new therapeutic strategies for BRCA2-mutated cancers.
Area of Science:
- Genetics
- Cancer Biology
- Immunology
Background:
- BRCA2 mutations are linked to early-onset breast cancer and DNA repair.
- The tumor-suppressing role of BRCA2 is primarily associated with homologous recombination (HR) DNA repair.
- Additional functions of BRCA2 beyond DNA repair are being investigated.
Purpose of the Study:
- To identify novel functions of BRCA2.
- To investigate the molecular consequences of BRCA2 loss in colorectal carcinoma cells.
- To explore the relationship between BRCA2 deficiency and interferon-related gene expression.
Main Methods:
- Generation of BRCA2-knockout HCT116 human colorectal carcinoma cells.
- Genome-wide microarray analyses to identify gene expression changes.
- Confirmation of gene expression in various BRCA2-deficient cell lines (human and mouse).
- Analysis of interferon-stimulated response element (ISRE) activity.
- Assessment of cell proliferation in the presence of interferons.
Main Results:
- BRCA2 loss up-regulates a subset of interferon (IFN)-related genes, including APOBEC3F and APOBEC3G.
- This up-regulation is independent of senescence and apoptosis and occurs in response to DNA damage or ionizing radiation.
- BRCA2 directly represses IFN-related gene expression via the ISRE.
- Interferon-beta (IFNβ) and Interferon-gamma (IFNγ) significantly reduce the colony-forming capacity of BRCA2-knockout cells.
Conclusions:
- BRCA2 plays a role in repressing interferon-related gene expression.
- Interferons show potential as therapeutic agents for cancers with BRCA2 mutations.
- Further research into BRCA2's role in immune gene regulation is warranted.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions

